Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2025-12-28 @ 7:59 AM
Study NCT ID:
NCT01858766
Status:
COMPLETED
Last Update Posted:
2018-11-14
First Post:
2013-05-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D006526', 'term': 'Hepatitis C'}, {'id': 'D006505', 'term': 'Hepatitis'}], 'ancestors': [{'id': 'D000086982', 'term': 'Blood-Borne Infections'}, {'id': 'D003141', 'term': 'Communicable Diseases'}, {'id': 'D007239', 'term': 'Infections'}, {'id': 'D006525', 'term': 'Hepatitis, Viral, Human'}, {'id': 'D014777', 'term': 'Virus Diseases'}, {'id': 'D018178', 'term': 'Flaviviridae Infections'}, {'id': 'D012327', 'term': 'RNA Virus Infections'}, {'id': 'D008107', 'term': 'Liver Diseases'}, {'id': 'D004066', 'term': 'Digestive System Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D000069474', 'term': 'Sofosbuvir'}, {'id': 'C000604171', 'term': 'velpatasvir'}, {'id': 'D012254', 'term': 'Ribavirin'}], 'ancestors': [{'id': 'D014542', 'term': 'Uridine Monophosphate'}, {'id': 'D014500', 'term': 'Uracil Nucleotides'}, {'id': 'D011742', 'term': 'Pyrimidine Nucleotides'}, {'id': 'D011743', 'term': 'Pyrimidines'}, {'id': 'D006573', 'term': 'Heterocyclic Compounds, 1-Ring'}, {'id': 'D006571', 'term': 'Heterocyclic Compounds'}, {'id': 'D009711', 'term': 'Nucleotides'}, {'id': 'D009706', 'term': 'Nucleic Acids, Nucleotides, and Nucleosides'}, {'id': 'D012265', 'term': 'Ribonucleotides'}, {'id': 'D012263', 'term': 'Ribonucleosides'}, {'id': 'D009705', 'term': 'Nucleosides'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'ClinicalTrialDisclosures@gilead.com', 'title': 'Clinical Trial Disclosures', 'organization': 'Gilead Sciences'}, 'certainAgreement': {'otherDetails': 'After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:\n\n* The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or\n* The study has been completed at all study sites for at least 2 years', 'restrictionType': 'OTHER', 'piSponsorEmployee': False, 'restrictiveAgreement': True}}, 'adverseEventsModule': {'timeFrame': 'Up to 12 weeks plus 30 days', 'description': 'Safety Analysis Set', 'eventGroups': [{'id': 'EG000', 'title': 'SOF+VEL 25 mg 12 Weeks', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (all genotypes)', 'otherNumAtRisk': 77, 'otherNumAffected': 38, 'seriousNumAtRisk': 77, 'seriousNumAffected': 2}, {'id': 'EG001', 'title': 'SOF+VEL 100 mg 12 Weeks', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (all genotypes)', 'otherNumAtRisk': 77, 'otherNumAffected': 45, 'seriousNumAtRisk': 77, 'seriousNumAffected': 1}, {'id': 'EG002', 'title': 'SOF+VEL 25 mg 8 Weeks', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (all genotypes)', 'otherNumAtRisk': 56, 'otherNumAffected': 27, 'seriousNumAtRisk': 56, 'seriousNumAffected': 3}, {'id': 'EG003', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (all genotypes)', 'otherNumAtRisk': 55, 'otherNumAffected': 43, 'seriousNumAtRisk': 55, 'seriousNumAffected': 1}, {'id': 'EG004', 'title': 'SOF+VEL 100 mg 8 Weeks', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (all genotypes)', 'otherNumAtRisk': 55, 'otherNumAffected': 22, 'seriousNumAtRisk': 55, 'seriousNumAffected': 0}, {'id': 'EG005', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (all genotypes)', 'otherNumAtRisk': 57, 'otherNumAffected': 36, 'seriousNumAtRisk': 57, 'seriousNumAffected': 0}], 'otherEvents': [{'term': 'Anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 2}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Abdominal pain upper', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Constipation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Diarrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 7}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 5}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 6}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Dyspepsia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 4}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Nausea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 10}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 8}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 4}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 7}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 7}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 8}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Vomiting', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 4}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Fatigue', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 19}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 14}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 7}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 17}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 21}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Bronchitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Influenza', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 3}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Nasopharyngitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 6}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 3}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Sinusitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Upper respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 4}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Arthralgia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Back pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Dizziness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 3}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Headache', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 16}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 14}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 7}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 21}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 9}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 10}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Anxiety', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 2}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Insomnia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 9}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 5}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Irritability', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 5}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 2}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Dysmenorrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Cough', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 2}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Dyspnoea exertional', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 2}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Oropharyngeal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 3}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Pruritus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 5}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Rash', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 7}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 3}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}], 'seriousEvents': [{'term': 'Cholecystitis acute', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Appendicitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Rib fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Traumatic liver injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Electrocardiogram ST segment elevation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Completed suicide', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Major depression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}, {'term': 'Calculus urinary', 'stats': [{'groupId': 'EG000', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 77, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 56, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 55, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 55, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 57, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 17.0'}], 'frequencyThreshold': '5'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Percentage of Participants With Sustained Virologic Response (SVR) 12 Weeks After Discontinuation of Therapy (SVR12)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '27', 'groupId': 'OG000'}, {'value': '28', 'groupId': 'OG001'}, {'value': '11', 'groupId': 'OG002'}, {'value': '10', 'groupId': 'OG003'}, {'value': '27', 'groupId': 'OG004'}, {'value': '27', 'groupId': 'OG005'}, {'value': '7', 'groupId': 'OG006'}, {'value': '7', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '30', 'groupId': 'OG011'}, {'value': '30', 'groupId': 'OG012'}, {'value': '29', 'groupId': 'OG013'}, {'value': '31', 'groupId': 'OG014'}, {'value': '26', 'groupId': 'OG015'}, {'value': '25', 'groupId': 'OG016'}, {'value': '26', 'groupId': 'OG017'}, {'value': '26', 'groupId': 'OG018'}]}], 'groups': [{'id': 'OG000', 'title': 'SOF+VEL 25 mg 12 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 1)'}, {'id': 'OG001', 'title': 'SOF+VEL 100 mg 12 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 1)'}, {'id': 'OG002', 'title': 'SOF+VEL 25 mg 12 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 2)'}, {'id': 'OG003', 'title': 'SOF+VEL 100 mg 12 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 2)'}, {'id': 'OG004', 'title': 'SOF+VEL 25 mg 12 Weeks (GT3)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 3)'}, {'id': 'OG005', 'title': 'SOF+VEL 100 mg 12 Weeks (GT3)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 3)'}, {'id': 'OG006', 'title': 'SOF+VEL 25 mg 12 Weeks (GT4)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 4)'}, {'id': 'OG007', 'title': 'SOF+VEL 100 mg 12 Weeks (GT4)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 4)'}, {'id': 'OG008', 'title': 'SOF+VEL 25 mg 12 Weeks (GT5)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 5)'}, {'id': 'OG009', 'title': 'SOF+VEL 25 mg 12 Weeks (GT6)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 6)'}, {'id': 'OG010', 'title': 'SOF+VEL 100 mg 12 Weeks (GT6)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 6)'}, {'id': 'OG011', 'title': 'SOF+VEL 25 mg 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (genotype 1)'}, {'id': 'OG012', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 1)'}, {'id': 'OG013', 'title': 'SOF+VEL 100 mg 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (genotype 1)'}, {'id': 'OG014', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 1)'}, {'id': 'OG015', 'title': 'SOF+VEL 25 mg 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (genotype 2)'}, {'id': 'OG016', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 2)'}, {'id': 'OG017', 'title': 'SOF+VEL 100 mg 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (genotype 2)'}, {'id': 'OG018', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 2)'}], 'classes': [{'categories': [{'measurements': [{'value': '96.3', 'groupId': 'OG000', 'lowerLimit': '81.0', 'upperLimit': '99.9'}, {'value': '100.0', 'groupId': 'OG001', 'lowerLimit': '87.7', 'upperLimit': '100.0'}, {'value': '90.9', 'groupId': 'OG002', 'lowerLimit': '58.7', 'upperLimit': '99.8'}, {'value': '100.0', 'groupId': 'OG003', 'lowerLimit': '69.2', 'upperLimit': '100.0'}, {'value': '92.6', 'groupId': 'OG004', 'lowerLimit': '75.7', 'upperLimit': '99.1'}, {'value': '92.6', 'groupId': 'OG005', 'lowerLimit': '75.7', 'upperLimit': '99.1'}, {'value': '100.0', 'groupId': 'OG006', 'lowerLimit': '59.0', 'upperLimit': '100.0'}, {'value': '85.7', 'groupId': 'OG007', 'lowerLimit': '42.1', 'upperLimit': '99.6'}, {'value': '100.0', 'groupId': 'OG008', 'lowerLimit': '2.5', 'upperLimit': '100.0'}, {'value': '100.0', 'groupId': 'OG009', 'lowerLimit': '39.8', 'upperLimit': '100.0'}, {'value': '100.0', 'groupId': 'OG010', 'lowerLimit': '47.8', 'upperLimit': '100.0'}, {'value': '86.7', 'groupId': 'OG011', 'lowerLimit': '69.3', 'upperLimit': '96.2'}, {'value': '83.3', 'groupId': 'OG012', 'lowerLimit': '65.3', 'upperLimit': '94.4'}, {'value': '89.7', 'groupId': 'OG013', 'lowerLimit': '72.6', 'upperLimit': '97.8'}, {'value': '80.6', 'groupId': 'OG014', 'lowerLimit': '62.5', 'upperLimit': '92.5'}, {'value': '76.9', 'groupId': 'OG015', 'lowerLimit': '56.4', 'upperLimit': '91.0'}, {'value': '88.0', 'groupId': 'OG016', 'lowerLimit': '68.8', 'upperLimit': '97.5'}, {'value': '88.5', 'groupId': 'OG017', 'lowerLimit': '69.8', 'upperLimit': '97.6'}, {'value': '88.5', 'groupId': 'OG018', 'lowerLimit': '69.8', 'upperLimit': '97.6'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Posttreatment Week 12', 'description': 'SVR12 was defined as HCV RNA \\< the lower limit of quantitation (LLOQ; ie, 15 IU/mL) at 12 weeks after stopping study treatment.', 'unitOfMeasure': 'percentage of participants', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Full Analysis Set: participants randomized into the study and received at least 1 dose of study drug.'}, {'type': 'PRIMARY', 'title': 'Percentage of Participants Who Permanently Discontinued Any Study Drug Due to an Adverse Event', 'denoms': [{'units': 'Participants', 'counts': [{'value': '77', 'groupId': 'OG000'}, {'value': '77', 'groupId': 'OG001'}, {'value': '56', 'groupId': 'OG002'}, {'value': '55', 'groupId': 'OG003'}, {'value': '55', 'groupId': 'OG004'}, {'value': '57', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'SOF+VEL 25 mg 12 Weeks', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (all genotypes)'}, {'id': 'OG001', 'title': 'SOF+VEL 100 mg 12 Weeks', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (all genotypes)'}, {'id': 'OG002', 'title': 'SOF+VEL 25 mg 8 Weeks', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (all genotypes)'}, {'id': 'OG003', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (all genotypes)'}, {'id': 'OG004', 'title': 'SOF+VEL 100 mg 8 Weeks', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (all genotypes)'}, {'id': 'OG005', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (all genotypes)'}], 'classes': [{'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1.8', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Up to 12 weeks', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'Safety Analysis Set'}, {'type': 'SECONDARY', 'title': 'Percentage of Participants With SVR at 4 and 24 Weeks After Discontinuation of Therapy (SVR4 and SVR24)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '27', 'groupId': 'OG000'}, {'value': '28', 'groupId': 'OG001'}, {'value': '11', 'groupId': 'OG002'}, {'value': '10', 'groupId': 'OG003'}, {'value': '27', 'groupId': 'OG004'}, {'value': '27', 'groupId': 'OG005'}, {'value': '7', 'groupId': 'OG006'}, {'value': '7', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '30', 'groupId': 'OG011'}, {'value': '30', 'groupId': 'OG012'}, {'value': '29', 'groupId': 'OG013'}, {'value': '31', 'groupId': 'OG014'}, {'value': '26', 'groupId': 'OG015'}, {'value': '25', 'groupId': 'OG016'}, {'value': '26', 'groupId': 'OG017'}, {'value': '26', 'groupId': 'OG018'}]}], 'groups': [{'id': 'OG000', 'title': 'SOF+VEL 25 mg 12 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 1)'}, {'id': 'OG001', 'title': 'SOF+VEL 100 mg 12 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 1)'}, {'id': 'OG002', 'title': 'SOF+VEL 25 mg 12 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 2)'}, {'id': 'OG003', 'title': 'SOF+VEL 100 mg 12 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 2)'}, {'id': 'OG004', 'title': 'SOF+VEL 25 mg 12 Weeks (GT3)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 3)'}, {'id': 'OG005', 'title': 'SOF+VEL 100 mg 12 Weeks (GT3)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 3)'}, {'id': 'OG006', 'title': 'SOF+VEL 25 mg 12 Weeks (GT4)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 4)'}, {'id': 'OG007', 'title': 'SOF+VEL 100 mg 12 Weeks (GT4)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 4)'}, {'id': 'OG008', 'title': 'SOF+VEL 25 mg 12 Weeks (GT5)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 5)'}, {'id': 'OG009', 'title': 'SOF+VEL 25 mg 12 Weeks (GT6)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 6)'}, {'id': 'OG010', 'title': 'SOF+VEL 100 mg 12 Weeks (GT6)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 6)'}, {'id': 'OG011', 'title': 'SOF+VEL 25 mg 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (genotype 1)'}, {'id': 'OG012', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 1)'}, {'id': 'OG013', 'title': 'SOF+VEL 100 mg 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (genotype 1)'}, {'id': 'OG014', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 1)'}, {'id': 'OG015', 'title': 'SOF+VEL 25 mg 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (genotype 2)'}, {'id': 'OG016', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 2)'}, {'id': 'OG017', 'title': 'SOF+VEL 100 mg 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (genotype 2)'}, {'id': 'OG018', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 2)'}], 'classes': [{'title': 'SVR4', 'categories': [{'measurements': [{'value': '96.3', 'groupId': 'OG000', 'lowerLimit': '81.0', 'upperLimit': '99.9'}, {'value': '100.0', 'groupId': 'OG001', 'lowerLimit': '87.7', 'upperLimit': '100.0'}, {'value': '90.9', 'groupId': 'OG002', 'lowerLimit': '58.7', 'upperLimit': '99.8'}, {'value': '100.0', 'groupId': 'OG003', 'lowerLimit': '69.2', 'upperLimit': '100.0'}, {'value': '92.6', 'groupId': 'OG004', 'lowerLimit': '75.7', 'upperLimit': '99.1'}, {'value': '100.0', 'groupId': 'OG005', 'lowerLimit': '87.2', 'upperLimit': '100.0'}, {'value': '100.0', 'groupId': 'OG006', 'lowerLimit': '59.0', 'upperLimit': '100.0'}, {'value': '85.7', 'groupId': 'OG007', 'lowerLimit': '42.1', 'upperLimit': '99.6'}, {'value': '100.0', 'groupId': 'OG008', 'lowerLimit': '2.5', 'upperLimit': '100.0'}, {'value': '100.0', 'groupId': 'OG009', 'lowerLimit': '39.8', 'upperLimit': '100.0'}, {'value': '100.0', 'groupId': 'OG010', 'lowerLimit': '47.8', 'upperLimit': '100.0'}, {'value': '86.7', 'groupId': 'OG011', 'lowerLimit': '69.3', 'upperLimit': '96.2'}, {'value': '83.3', 'groupId': 'OG012', 'lowerLimit': '65.3', 'upperLimit': '94.4'}, {'value': '93.1', 'groupId': 'OG013', 'lowerLimit': '77.2', 'upperLimit': '99.2'}, {'value': '87.1', 'groupId': 'OG014', 'lowerLimit': '70.2', 'upperLimit': '96.4'}, {'value': '88.5', 'groupId': 'OG015', 'lowerLimit': '69.8', 'upperLimit': '97.6'}, {'value': '88.0', 'groupId': 'OG016', 'lowerLimit': '68.8', 'upperLimit': '97.5'}, {'value': '92.3', 'groupId': 'OG017', 'lowerLimit': '74.9', 'upperLimit': '99.1'}, {'value': '88.5', 'groupId': 'OG018', 'lowerLimit': '69.8', 'upperLimit': '97.6'}]}]}, {'title': 'SVR24', 'categories': [{'measurements': [{'value': '92.6', 'groupId': 'OG000', 'lowerLimit': '75.7', 'upperLimit': '99.1'}, {'value': '100.0', 'groupId': 'OG001', 'lowerLimit': '87.7', 'upperLimit': '100.0'}, {'value': '90.9', 'groupId': 'OG002', 'lowerLimit': '58.7', 'upperLimit': '99.8'}, {'value': '100.0', 'groupId': 'OG003', 'lowerLimit': '69.2', 'upperLimit': '100.0'}, {'value': '92.6', 'groupId': 'OG004', 'lowerLimit': '75.7', 'upperLimit': '99.1'}, {'value': '92.6', 'groupId': 'OG005', 'lowerLimit': '75.7', 'upperLimit': '99.1'}, {'value': '100.0', 'groupId': 'OG006', 'lowerLimit': '59.0', 'upperLimit': '100.0'}, {'value': '85.7', 'groupId': 'OG007', 'lowerLimit': '42.1', 'upperLimit': '99.6'}, {'value': '100.0', 'groupId': 'OG008', 'lowerLimit': '2.5', 'upperLimit': '100.0'}, {'value': '100.0', 'groupId': 'OG009', 'lowerLimit': '39.8', 'upperLimit': '100.0'}, {'value': '100.0', 'groupId': 'OG010', 'lowerLimit': '47.8', 'upperLimit': '100.0'}, {'value': '86.7', 'groupId': 'OG011', 'lowerLimit': '69.3', 'upperLimit': '96.2'}, {'value': '83.3', 'groupId': 'OG012', 'lowerLimit': '65.3', 'upperLimit': '94.4'}, {'value': '89.7', 'groupId': 'OG013', 'lowerLimit': '72.6', 'upperLimit': '97.8'}, {'value': '80.6', 'groupId': 'OG014', 'lowerLimit': '62.5', 'upperLimit': '92.5'}, {'value': '76.9', 'groupId': 'OG015', 'lowerLimit': '56.4', 'upperLimit': '91.0'}, {'value': '88.0', 'groupId': 'OG016', 'lowerLimit': '68.8', 'upperLimit': '97.5'}, {'value': '88.5', 'groupId': 'OG017', 'lowerLimit': '69.8', 'upperLimit': '97.6'}, {'value': '88.5', 'groupId': 'OG018', 'lowerLimit': '69.8', 'upperLimit': '97.6'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Posttreatment Weeks 4 and 24', 'description': 'SVR4 and SVR 24 were defined as HCV RNA \\< LLOQ at 4 and 24 weeks after stopping study treatment, respectively.', 'unitOfMeasure': 'percentage of participants', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Full Analysis Set'}, {'type': 'SECONDARY', 'title': 'Percentage of Participants With Virologic Failure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '27', 'groupId': 'OG000'}, {'value': '28', 'groupId': 'OG001'}, {'value': '11', 'groupId': 'OG002'}, {'value': '10', 'groupId': 'OG003'}, {'value': '27', 'groupId': 'OG004'}, {'value': '27', 'groupId': 'OG005'}, {'value': '7', 'groupId': 'OG006'}, {'value': '7', 'groupId': 'OG007'}, {'value': '1', 'groupId': 'OG008'}, {'value': '4', 'groupId': 'OG009'}, {'value': '5', 'groupId': 'OG010'}, {'value': '30', 'groupId': 'OG011'}, {'value': '30', 'groupId': 'OG012'}, {'value': '29', 'groupId': 'OG013'}, {'value': '31', 'groupId': 'OG014'}, {'value': '26', 'groupId': 'OG015'}, {'value': '25', 'groupId': 'OG016'}, {'value': '26', 'groupId': 'OG017'}, {'value': '26', 'groupId': 'OG018'}]}], 'groups': [{'id': 'OG000', 'title': 'SOF+VEL 25 mg 12 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 1)'}, {'id': 'OG001', 'title': 'SOF+VEL 100 mg 12 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 1)'}, {'id': 'OG002', 'title': 'SOF+VEL 25 mg 12 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 2)'}, {'id': 'OG003', 'title': 'SOF+VEL 100 mg 12 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 2)'}, {'id': 'OG004', 'title': 'SOF+VEL 25 mg 12 Weeks (GT3)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 3)'}, {'id': 'OG005', 'title': 'SOF+VEL 100 mg 12 Weeks (GT3)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 3)'}, {'id': 'OG006', 'title': 'SOF+VEL 25 mg 12 Weeks (GT4)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 4)'}, {'id': 'OG007', 'title': 'SOF+VEL 100 mg 12 Weeks (GT4)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 4)'}, {'id': 'OG008', 'title': 'SOF+VEL 25 mg 12 Weeks (GT5)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 5)'}, {'id': 'OG009', 'title': 'SOF+VEL 25 mg 12 Weeks (GT6)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 6)'}, {'id': 'OG010', 'title': 'SOF+VEL 100 mg 12 Weeks (GT6)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 6)'}, {'id': 'OG011', 'title': 'SOF+VEL 25 mg 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (genotype 1)'}, {'id': 'OG012', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 1)'}, {'id': 'OG013', 'title': 'SOF+VEL 100 mg 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (genotype 1)'}, {'id': 'OG014', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 1)'}, {'id': 'OG015', 'title': 'SOF+VEL 25 mg 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (genotype 2)'}, {'id': 'OG016', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 2)'}, {'id': 'OG017', 'title': 'SOF+VEL 100 mg 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (genotype 2)'}, {'id': 'OG018', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 2)'}], 'classes': [{'categories': [{'measurements': [{'value': '3.7', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '7.4', 'groupId': 'OG004'}, {'value': '7.4', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}, {'value': '0', 'groupId': 'OG008'}, {'value': '0', 'groupId': 'OG009'}, {'value': '0', 'groupId': 'OG010'}, {'value': '10.0', 'groupId': 'OG011'}, {'value': '16.7', 'groupId': 'OG012'}, {'value': '10.3', 'groupId': 'OG013'}, {'value': '16.1', 'groupId': 'OG014'}, {'value': '23.1', 'groupId': 'OG015'}, {'value': '8.0', 'groupId': 'OG016'}, {'value': '11.5', 'groupId': 'OG017'}, {'value': '11.5', 'groupId': 'OG018'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Up to Posttreatment Week 24', 'description': 'Virologic failure was defined as:\n\n* On-treatment virologic failure:\n\n * Breakthrough (confirmed HCV RNA ≥ LLOQ after having previously had HCV RNA \\< LLOQ while on treatment), or\n * Rebound (confirmed \\> 1 log10 IU/mL increase in HCV RNA from nadir while on treatment), or\n * Non-response (HCV RNA persistently ≥ LLOQ through 8 weeks of treatment)\n* Virologic relapse:\n\n * Confirmed HCV RNA ≥ LLOQ during the posttreatment period having achieved HCV RNA \\< LLOQ at last on-treatment visit.', 'unitOfMeasure': 'percentage of participants', 'reportingStatus': 'POSTED', 'populationDescription': 'Full Analysis Set'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'SOF+VEL 25 mg 12 Weeks (GT1)', 'description': 'Sofosbuvir (SOF) 400 mg tablet + velpatasvir (VEL) 25 mg tablet administered orally once daily for 12 weeks (genotype (GT) 1)'}, {'id': 'FG001', 'title': 'SOF+VEL 100 mg 12 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 1)'}, {'id': 'FG002', 'title': 'SOF+VEL 25 mg 12 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 2)'}, {'id': 'FG003', 'title': 'SOF+VEL 100 mg 12 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 2)'}, {'id': 'FG004', 'title': 'SOF+VEL 25 mg 12 Weeks (GT3)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 3)'}, {'id': 'FG005', 'title': 'SOF+VEL 100 mg 12 Weeks (GT3)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 3)'}, {'id': 'FG006', 'title': 'SOF+VEL 25 mg 12 Weeks (GT4)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 4)'}, {'id': 'FG007', 'title': 'SOF+VEL 100 mg 12 Weeks (GT4)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 4)'}, {'id': 'FG008', 'title': 'SOF+VEL 25 mg 12 Weeks (GT5)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 5)'}, {'id': 'FG009', 'title': 'SOF+VEL 25 mg 12 Weeks (GT6)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 6)'}, {'id': 'FG010', 'title': 'SOF+VEL 100 mg 12 Weeks (GT6)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 6)'}, {'id': 'FG011', 'title': 'SOF+VEL 25 mg 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (genotype 1)'}, {'id': 'FG012', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + ribavirin (RBV) tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 1)'}, {'id': 'FG013', 'title': 'SOF+VEL 100 mg 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (genotype 1)'}, {'id': 'FG014', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 1)'}, {'id': 'FG015', 'title': 'SOF+VEL 25 mg 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (genotype 2)'}, {'id': 'FG016', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 2)'}, {'id': 'FG017', 'title': 'SOF+VEL 100 mg 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (genotype 2)'}, {'id': 'FG018', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 2)'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '27'}, {'groupId': 'FG001', 'numSubjects': '28'}, {'groupId': 'FG002', 'numSubjects': '11'}, {'groupId': 'FG003', 'numSubjects': '10'}, {'groupId': 'FG004', 'numSubjects': '27'}, {'groupId': 'FG005', 'numSubjects': '28'}, {'groupId': 'FG006', 'numSubjects': '7'}, {'groupId': 'FG007', 'numSubjects': '7'}, {'groupId': 'FG008', 'numSubjects': '1'}, {'groupId': 'FG009', 'numSubjects': '4'}, {'groupId': 'FG010', 'numSubjects': '5'}, {'groupId': 'FG011', 'numSubjects': '30'}, {'groupId': 'FG012', 'numSubjects': '30'}, {'groupId': 'FG013', 'numSubjects': '29'}, {'groupId': 'FG014', 'numSubjects': '31'}, {'groupId': 'FG015', 'numSubjects': '26'}, {'groupId': 'FG016', 'numSubjects': '25'}, {'groupId': 'FG017', 'numSubjects': '27'}, {'groupId': 'FG018', 'numSubjects': '26'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '26'}, {'groupId': 'FG001', 'numSubjects': '28'}, {'groupId': 'FG002', 'numSubjects': '10'}, {'groupId': 'FG003', 'numSubjects': '10'}, {'groupId': 'FG004', 'numSubjects': '26'}, {'groupId': 'FG005', 'numSubjects': '24'}, {'groupId': 'FG006', 'numSubjects': '7'}, {'groupId': 'FG007', 'numSubjects': '5'}, {'groupId': 'FG008', 'numSubjects': '1'}, {'groupId': 'FG009', 'numSubjects': '4'}, {'groupId': 'FG010', 'numSubjects': '5'}, {'groupId': 'FG011', 'numSubjects': '25'}, {'groupId': 'FG012', 'numSubjects': '25'}, {'groupId': 'FG013', 'numSubjects': '26'}, {'groupId': 'FG014', 'numSubjects': '23'}, {'groupId': 'FG015', 'numSubjects': '20'}, {'groupId': 'FG016', 'numSubjects': '22'}, {'groupId': 'FG017', 'numSubjects': '23'}, {'groupId': 'FG018', 'numSubjects': '22'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '1'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '1'}, {'groupId': 'FG005', 'numSubjects': '4'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '2'}, {'groupId': 'FG008', 'numSubjects': '0'}, {'groupId': 'FG009', 'numSubjects': '0'}, {'groupId': 'FG010', 'numSubjects': '0'}, {'groupId': 'FG011', 'numSubjects': '5'}, {'groupId': 'FG012', 'numSubjects': '5'}, {'groupId': 'FG013', 'numSubjects': '3'}, {'groupId': 'FG014', 'numSubjects': '8'}, {'groupId': 'FG015', 'numSubjects': '6'}, {'groupId': 'FG016', 'numSubjects': '3'}, {'groupId': 'FG017', 'numSubjects': '4'}, {'groupId': 'FG018', 'numSubjects': '4'}]}], 'dropWithdraws': [{'type': 'Randomized but Never Treated', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '1'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '0'}, {'groupId': 'FG009', 'numSubjects': '0'}, {'groupId': 'FG010', 'numSubjects': '0'}, {'groupId': 'FG011', 'numSubjects': '0'}, {'groupId': 'FG012', 'numSubjects': '0'}, {'groupId': 'FG013', 'numSubjects': '0'}, {'groupId': 'FG014', 'numSubjects': '0'}, {'groupId': 'FG015', 'numSubjects': '0'}, {'groupId': 'FG016', 'numSubjects': '0'}, {'groupId': 'FG017', 'numSubjects': '1'}, {'groupId': 'FG018', 'numSubjects': '0'}]}, {'type': 'Death', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '1'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '0'}, {'groupId': 'FG009', 'numSubjects': '0'}, {'groupId': 'FG010', 'numSubjects': '0'}, {'groupId': 'FG011', 'numSubjects': '0'}, {'groupId': 'FG012', 'numSubjects': '0'}, {'groupId': 'FG013', 'numSubjects': '0'}, {'groupId': 'FG014', 'numSubjects': '0'}, {'groupId': 'FG015', 'numSubjects': '0'}, {'groupId': 'FG016', 'numSubjects': '0'}, {'groupId': 'FG017', 'numSubjects': '0'}, {'groupId': 'FG018', 'numSubjects': '0'}]}, {'type': 'Lack of Efficacy', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '1'}, {'groupId': 'FG005', 'numSubjects': '2'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '0'}, {'groupId': 'FG009', 'numSubjects': '0'}, {'groupId': 'FG010', 'numSubjects': '0'}, {'groupId': 'FG011', 'numSubjects': '3'}, {'groupId': 'FG012', 'numSubjects': '5'}, {'groupId': 'FG013', 'numSubjects': '3'}, {'groupId': 'FG014', 'numSubjects': '5'}, {'groupId': 'FG015', 'numSubjects': '5'}, {'groupId': 'FG016', 'numSubjects': '2'}, {'groupId': 'FG017', 'numSubjects': '3'}, {'groupId': 'FG018', 'numSubjects': '3'}]}, {'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '1'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '2'}, {'groupId': 'FG008', 'numSubjects': '0'}, {'groupId': 'FG009', 'numSubjects': '0'}, {'groupId': 'FG010', 'numSubjects': '0'}, {'groupId': 'FG011', 'numSubjects': '1'}, {'groupId': 'FG012', 'numSubjects': '0'}, {'groupId': 'FG013', 'numSubjects': '0'}, {'groupId': 'FG014', 'numSubjects': '3'}, {'groupId': 'FG015', 'numSubjects': '1'}, {'groupId': 'FG016', 'numSubjects': '1'}, {'groupId': 'FG017', 'numSubjects': '0'}, {'groupId': 'FG018', 'numSubjects': '1'}]}, {'type': 'Withdrew Consent', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '0'}, {'groupId': 'FG009', 'numSubjects': '0'}, {'groupId': 'FG010', 'numSubjects': '0'}, {'groupId': 'FG011', 'numSubjects': '1'}, {'groupId': 'FG012', 'numSubjects': '0'}, {'groupId': 'FG013', 'numSubjects': '0'}, {'groupId': 'FG014', 'numSubjects': '0'}, {'groupId': 'FG015', 'numSubjects': '0'}, {'groupId': 'FG016', 'numSubjects': '0'}, {'groupId': 'FG017', 'numSubjects': '0'}, {'groupId': 'FG018', 'numSubjects': '0'}]}]}], 'recruitmentDetails': 'Participants were enrolled at study sites in the United States. The first participant was screened on 22 April 2013. The last study visit occurred on 12 August 2014.', 'preAssignmentDetails': '469 participants were screened.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '27', 'groupId': 'BG000'}, {'value': '28', 'groupId': 'BG001'}, {'value': '11', 'groupId': 'BG002'}, {'value': '10', 'groupId': 'BG003'}, {'value': '27', 'groupId': 'BG004'}, {'value': '27', 'groupId': 'BG005'}, {'value': '7', 'groupId': 'BG006'}, {'value': '7', 'groupId': 'BG007'}, {'value': '1', 'groupId': 'BG008'}, {'value': '4', 'groupId': 'BG009'}, {'value': '5', 'groupId': 'BG010'}, {'value': '30', 'groupId': 'BG011'}, {'value': '30', 'groupId': 'BG012'}, {'value': '29', 'groupId': 'BG013'}, {'value': '31', 'groupId': 'BG014'}, {'value': '26', 'groupId': 'BG015'}, {'value': '25', 'groupId': 'BG016'}, {'value': '26', 'groupId': 'BG017'}, {'value': '26', 'groupId': 'BG018'}, {'value': '377', 'groupId': 'BG019'}]}], 'groups': [{'id': 'BG000', 'title': 'SOF+VEL 25 mg 12 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 1)'}, {'id': 'BG001', 'title': 'SOF+VEL 100 mg 12 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 1)'}, {'id': 'BG002', 'title': 'SOF+VEL 25 mg 12 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 2)'}, {'id': 'BG003', 'title': 'SOF+VEL 100 mg 12 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 2)'}, {'id': 'BG004', 'title': 'SOF+VEL 25 mg 12 Weeks (GT3)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 3)'}, {'id': 'BG005', 'title': 'SOF+VEL 100 mg 12 Weeks (GT3)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 3)'}, {'id': 'BG006', 'title': 'SOF+VEL 25 mg 12 Weeks (GT4)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 4)'}, {'id': 'BG007', 'title': 'SOF+VEL 100 mg 12 Weeks (GT4)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 4)'}, {'id': 'BG008', 'title': 'SOF+VEL 25 mg 12 Weeks (GT5)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 5)'}, {'id': 'BG009', 'title': 'SOF+VEL 25 mg 12 Weeks (GT6)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 12 weeks (genotype 6)'}, {'id': 'BG010', 'title': 'SOF+VEL 100 mg 12 Weeks (GT6)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 12 weeks (genotype 6)'}, {'id': 'BG011', 'title': 'SOF+VEL 25 mg 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (genotype 1)'}, {'id': 'BG012', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 1)'}, {'id': 'BG013', 'title': 'SOF+VEL 100 mg 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (genotype 1)'}, {'id': 'BG014', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks (GT1)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 1)'}, {'id': 'BG015', 'title': 'SOF+VEL 25 mg 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily for 8 weeks (genotype 2)'}, {'id': 'BG016', 'title': 'SOF+VEL 25 mg + RBV 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 25 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 2)'}, {'id': 'BG017', 'title': 'SOF+VEL 100 mg 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily for 8 weeks (genotype 2)'}, {'id': 'BG018', 'title': 'SOF+VEL 100 mg + RBV 8 Weeks (GT2)', 'description': 'SOF 400 mg tablet + VEL 100 mg tablet administered orally once daily + RBV tablets (1000 or 1200 mg daily based on weight) for 8 weeks (genotype 2)'}, {'id': 'BG019', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '49', 'spread': '11.4', 'groupId': 'BG000'}, {'value': '49', 'spread': '12.2', 'groupId': 'BG001'}, {'value': '42', 'spread': '14.6', 'groupId': 'BG002'}, {'value': '53', 'spread': '12.6', 'groupId': 'BG003'}, {'value': '52', 'spread': '10.8', 'groupId': 'BG004'}, {'value': '50', 'spread': '12.7', 'groupId': 'BG005'}, {'value': '51', 'spread': '16.1', 'groupId': 'BG006'}, {'value': '56', 'spread': '5.5', 'groupId': 'BG007'}, {'value': '53', 'spread': 'NA', 'comment': 'N/A because there is only 1 participant in this group.', 'groupId': 'BG008'}, {'value': '57', 'spread': '4.8', 'groupId': 'BG009'}, {'value': '54', 'spread': '9.3', 'groupId': 'BG010'}, {'value': '50', 'spread': '10.7', 'groupId': 'BG011'}, {'value': '53', 'spread': '8.5', 'groupId': 'BG012'}, {'value': '55', 'spread': '9.6', 'groupId': 'BG013'}, {'value': '52', 'spread': '13.8', 'groupId': 'BG014'}, {'value': '52', 'spread': '10.8', 'groupId': 'BG015'}, {'value': '54', 'spread': '11.5', 'groupId': 'BG016'}, {'value': '54', 'spread': '10.8', 'groupId': 'BG017'}, {'value': '51', 'spread': '9.4', 'groupId': 'BG018'}, {'value': '52', 'spread': '11.3', 'groupId': 'BG019'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '13', 'groupId': 'BG000'}, {'value': '11', 'groupId': 'BG001'}, {'value': '5', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '9', 'groupId': 'BG004'}, {'value': '10', 'groupId': 'BG005'}, {'value': '1', 'groupId': 'BG006'}, {'value': '3', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '1', 'groupId': 'BG010'}, {'value': '14', 'groupId': 'BG011'}, {'value': '12', 'groupId': 'BG012'}, {'value': '13', 'groupId': 'BG013'}, {'value': '15', 'groupId': 'BG014'}, {'value': '11', 'groupId': 'BG015'}, {'value': '8', 'groupId': 'BG016'}, {'value': '14', 'groupId': 'BG017'}, {'value': '16', 'groupId': 'BG018'}, {'value': '159', 'groupId': 'BG019'}]}, {'title': 'Male', 'measurements': [{'value': '14', 'groupId': 'BG000'}, {'value': '17', 'groupId': 'BG001'}, {'value': '6', 'groupId': 'BG002'}, {'value': '7', 'groupId': 'BG003'}, {'value': '18', 'groupId': 'BG004'}, {'value': '17', 'groupId': 'BG005'}, {'value': '6', 'groupId': 'BG006'}, {'value': '4', 'groupId': 'BG007'}, {'value': '1', 'groupId': 'BG008'}, {'value': '4', 'groupId': 'BG009'}, {'value': '4', 'groupId': 'BG010'}, {'value': '16', 'groupId': 'BG011'}, {'value': '18', 'groupId': 'BG012'}, {'value': '16', 'groupId': 'BG013'}, {'value': '16', 'groupId': 'BG014'}, {'value': '15', 'groupId': 'BG015'}, {'value': '17', 'groupId': 'BG016'}, {'value': '12', 'groupId': 'BG017'}, {'value': '10', 'groupId': 'BG018'}, {'value': '218', 'groupId': 'BG019'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Ethnicity (NIH/OMB)', 'classes': [{'categories': [{'title': 'Hispanic or Latino', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '2', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '1', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '4', 'groupId': 'BG011'}, {'value': '1', 'groupId': 'BG012'}, {'value': '2', 'groupId': 'BG013'}, {'value': '1', 'groupId': 'BG014'}, {'value': '3', 'groupId': 'BG015'}, {'value': '2', 'groupId': 'BG016'}, {'value': '7', 'groupId': 'BG017'}, {'value': '5', 'groupId': 'BG018'}, {'value': '39', 'groupId': 'BG019'}]}, {'title': 'Not Hispanic or Latino', 'measurements': [{'value': '23', 'groupId': 'BG000'}, {'value': '23', 'groupId': 'BG001'}, {'value': '10', 'groupId': 'BG002'}, {'value': '10', 'groupId': 'BG003'}, {'value': '25', 'groupId': 'BG004'}, {'value': '26', 'groupId': 'BG005'}, {'value': '7', 'groupId': 'BG006'}, {'value': '6', 'groupId': 'BG007'}, {'value': '1', 'groupId': 'BG008'}, {'value': '4', 'groupId': 'BG009'}, {'value': '5', 'groupId': 'BG010'}, {'value': '26', 'groupId': 'BG011'}, {'value': '29', 'groupId': 'BG012'}, {'value': '27', 'groupId': 'BG013'}, {'value': '30', 'groupId': 'BG014'}, {'value': '23', 'groupId': 'BG015'}, {'value': '23', 'groupId': 'BG016'}, {'value': '19', 'groupId': 'BG017'}, {'value': '21', 'groupId': 'BG018'}, {'value': '338', 'groupId': 'BG019'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '0', 'groupId': 'BG019'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race/Ethnicity, Customized', 'classes': [{'title': 'American Indian or Alaska Native', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '1', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '2', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '1', 'groupId': 'BG018'}, {'value': '6', 'groupId': 'BG019'}]}]}, {'title': 'Asian', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '2', 'groupId': 'BG009'}, {'value': '4', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '7', 'groupId': 'BG019'}]}]}, {'title': 'Black or African American', 'categories': [{'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '1', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '4', 'groupId': 'BG011'}, {'value': '3', 'groupId': 'BG012'}, {'value': '5', 'groupId': 'BG013'}, {'value': '5', 'groupId': 'BG014'}, {'value': '2', 'groupId': 'BG015'}, {'value': '2', 'groupId': 'BG016'}, {'value': '2', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '35', 'groupId': 'BG019'}]}]}, {'title': 'White', 'categories': [{'measurements': [{'value': '23', 'groupId': 'BG000'}, {'value': '25', 'groupId': 'BG001'}, {'value': '11', 'groupId': 'BG002'}, {'value': '10', 'groupId': 'BG003'}, {'value': '22', 'groupId': 'BG004'}, {'value': '26', 'groupId': 'BG005'}, {'value': '5', 'groupId': 'BG006'}, {'value': '5', 'groupId': 'BG007'}, {'value': '1', 'groupId': 'BG008'}, {'value': '2', 'groupId': 'BG009'}, {'value': '1', 'groupId': 'BG010'}, {'value': '26', 'groupId': 'BG011'}, {'value': '27', 'groupId': 'BG012'}, {'value': '24', 'groupId': 'BG013'}, {'value': '24', 'groupId': 'BG014'}, {'value': '22', 'groupId': 'BG015'}, {'value': '23', 'groupId': 'BG016'}, {'value': '24', 'groupId': 'BG017'}, {'value': '25', 'groupId': 'BG018'}, {'value': '326', 'groupId': 'BG019'}]}]}, {'title': 'Other', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '2', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '3', 'groupId': 'BG019'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}, {'title': 'HCV Genotype', 'classes': [{'title': 'Genotype 1a', 'categories': [{'measurements': [{'value': '22', 'groupId': 'BG000'}, {'value': '21', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '25', 'groupId': 'BG011'}, {'value': '25', 'groupId': 'BG012'}, {'value': '24', 'groupId': 'BG013'}, {'value': '25', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '142', 'groupId': 'BG019'}]}]}, {'title': 'Genotype 1b', 'categories': [{'measurements': [{'value': '5', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '5', 'groupId': 'BG011'}, {'value': '5', 'groupId': 'BG012'}, {'value': '5', 'groupId': 'BG013'}, {'value': '6', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '32', 'groupId': 'BG019'}]}]}, {'title': 'Genotype 1g', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '1', 'groupId': 'BG019'}]}]}, {'title': 'Genotype 2', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '11', 'groupId': 'BG002'}, {'value': '10', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '26', 'groupId': 'BG015'}, {'value': '25', 'groupId': 'BG016'}, {'value': '26', 'groupId': 'BG017'}, {'value': '26', 'groupId': 'BG018'}, {'value': '124', 'groupId': 'BG019'}]}]}, {'title': 'Genotype 3', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '27', 'groupId': 'BG004'}, {'value': '27', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '54', 'groupId': 'BG019'}]}]}, {'title': 'Genotype 4', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '7', 'groupId': 'BG006'}, {'value': '7', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '14', 'groupId': 'BG019'}]}]}, {'title': 'Genotype 5', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '1', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '1', 'groupId': 'BG019'}]}]}, {'title': 'Genotype 6', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '4', 'groupId': 'BG009'}, {'value': '5', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '0', 'groupId': 'BG018'}, {'value': '9', 'groupId': 'BG019'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}, {'title': 'IL28b Status', 'classes': [{'title': 'CC', 'categories': [{'measurements': [{'value': '8', 'groupId': 'BG000'}, {'value': '9', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '12', 'groupId': 'BG004'}, {'value': '13', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '2', 'groupId': 'BG007'}, {'value': '1', 'groupId': 'BG008'}, {'value': '1', 'groupId': 'BG009'}, {'value': '5', 'groupId': 'BG010'}, {'value': '9', 'groupId': 'BG011'}, {'value': '10', 'groupId': 'BG012'}, {'value': '13', 'groupId': 'BG013'}, {'value': '9', 'groupId': 'BG014'}, {'value': '9', 'groupId': 'BG015'}, {'value': '13', 'groupId': 'BG016'}, {'value': '9', 'groupId': 'BG017'}, {'value': '7', 'groupId': 'BG018'}, {'value': '135', 'groupId': 'BG019'}]}]}, {'title': 'CT', 'categories': [{'measurements': [{'value': '16', 'groupId': 'BG000'}, {'value': '17', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '8', 'groupId': 'BG003'}, {'value': '13', 'groupId': 'BG004'}, {'value': '12', 'groupId': 'BG005'}, {'value': '5', 'groupId': 'BG006'}, {'value': '2', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '3', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '14', 'groupId': 'BG011'}, {'value': '16', 'groupId': 'BG012'}, {'value': '13', 'groupId': 'BG013'}, {'value': '18', 'groupId': 'BG014'}, {'value': '14', 'groupId': 'BG015'}, {'value': '9', 'groupId': 'BG016'}, {'value': '14', 'groupId': 'BG017'}, {'value': '14', 'groupId': 'BG018'}, {'value': '196', 'groupId': 'BG019'}]}]}, {'title': 'TT', 'categories': [{'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '2', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '3', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '7', 'groupId': 'BG011'}, {'value': '4', 'groupId': 'BG012'}, {'value': '3', 'groupId': 'BG013'}, {'value': '4', 'groupId': 'BG014'}, {'value': '3', 'groupId': 'BG015'}, {'value': '3', 'groupId': 'BG016'}, {'value': '3', 'groupId': 'BG017'}, {'value': '3', 'groupId': 'BG018'}, {'value': '43', 'groupId': 'BG019'}]}]}, {'title': 'Missing', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '0', 'groupId': 'BG009'}, {'value': '0', 'groupId': 'BG010'}, {'value': '0', 'groupId': 'BG011'}, {'value': '0', 'groupId': 'BG012'}, {'value': '0', 'groupId': 'BG013'}, {'value': '0', 'groupId': 'BG014'}, {'value': '0', 'groupId': 'BG015'}, {'value': '0', 'groupId': 'BG016'}, {'value': '0', 'groupId': 'BG017'}, {'value': '2', 'groupId': 'BG018'}, {'value': '3', 'groupId': 'BG019'}]}]}], 'paramType': 'NUMBER', 'description': 'The CC, CT, and TT alleles are different forms of the IL28b gene.', 'unitOfMeasure': 'participants'}, {'title': 'HCV RNA', 'classes': [{'categories': [{'measurements': [{'value': '6.4', 'spread': '0.60', 'groupId': 'BG000'}, {'value': '6.4', 'spread': '0.74', 'groupId': 'BG001'}, {'value': '6.5', 'spread': '0.74', 'groupId': 'BG002'}, {'value': '6.7', 'spread': '0.78', 'groupId': 'BG003'}, {'value': '6.4', 'spread': '1.09', 'groupId': 'BG004'}, {'value': '6.2', 'spread': '0.74', 'groupId': 'BG005'}, {'value': '6.2', 'spread': '0.58', 'groupId': 'BG006'}, {'value': '5.8', 'spread': '0.55', 'groupId': 'BG007'}, {'value': '7.0', 'spread': 'NA', 'comment': 'N/A because there is only 1 participant in this group.', 'groupId': 'BG008'}, {'value': '6.1', 'spread': '0.89', 'groupId': 'BG009'}, {'value': '6.7', 'spread': '0.88', 'groupId': 'BG010'}, {'value': '6.5', 'spread': '0.69', 'groupId': 'BG011'}, {'value': '6.5', 'spread': '0.63', 'groupId': 'BG012'}, {'value': '6.3', 'spread': '0.85', 'groupId': 'BG013'}, {'value': '6.6', 'spread': '0.55', 'groupId': 'BG014'}, {'value': '6.4', 'spread': '0.87', 'groupId': 'BG015'}, {'value': '6.6', 'spread': '0.80', 'groupId': 'BG016'}, {'value': '6.5', 'spread': '0.74', 'groupId': 'BG017'}, {'value': '6.7', 'spread': '0.57', 'groupId': 'BG018'}, {'value': '6.5', 'spread': '0.75', 'groupId': 'BG019'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'log10 IU/mL', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'HCV RNA Category', 'classes': [{'title': '< 800,000 IU/mL', 'categories': [{'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '9', 'groupId': 'BG004'}, {'value': '6', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '4', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}, {'value': '1', 'groupId': 'BG009'}, {'value': '1', 'groupId': 'BG010'}, {'value': '5', 'groupId': 'BG011'}, {'value': '5', 'groupId': 'BG012'}, {'value': '8', 'groupId': 'BG013'}, {'value': '3', 'groupId': 'BG014'}, {'value': '6', 'groupId': 'BG015'}, {'value': '4', 'groupId': 'BG016'}, {'value': '5', 'groupId': 'BG017'}, {'value': '2', 'groupId': 'BG018'}, {'value': '74', 'groupId': 'BG019'}]}]}, {'title': '≥ 800,000 IU/mL', 'categories': [{'measurements': [{'value': '23', 'groupId': 'BG000'}, {'value': '22', 'groupId': 'BG001'}, {'value': '9', 'groupId': 'BG002'}, {'value': '9', 'groupId': 'BG003'}, {'value': '18', 'groupId': 'BG004'}, {'value': '21', 'groupId': 'BG005'}, {'value': '5', 'groupId': 'BG006'}, {'value': '3', 'groupId': 'BG007'}, {'value': '1', 'groupId': 'BG008'}, {'value': '3', 'groupId': 'BG009'}, {'value': '4', 'groupId': 'BG010'}, {'value': '25', 'groupId': 'BG011'}, {'value': '25', 'groupId': 'BG012'}, {'value': '21', 'groupId': 'BG013'}, {'value': '28', 'groupId': 'BG014'}, {'value': '20', 'groupId': 'BG015'}, {'value': '21', 'groupId': 'BG016'}, {'value': '21', 'groupId': 'BG017'}, {'value': '24', 'groupId': 'BG018'}, {'value': '303', 'groupId': 'BG019'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}], 'populationDescription': 'Safety Analysis Set: participants who were randomized and received at least 1 dose of study drug.'}}, 'protocolSection': {'designModule': {'phases': ['PHASE2'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 379}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2013-04'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2016-07', 'dispFirstSubmitDate': '2015-01-16', 'completionDateStruct': {'date': '2014-08', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2018-10-19', 'studyFirstSubmitDate': '2013-05-10', 'dispFirstSubmitQcDate': '2015-01-16', 'resultsFirstSubmitDate': '2016-07-27', 'studyFirstSubmitQcDate': '2013-05-20', 'dispFirstPostDateStruct': {'date': '2015-01-28', 'type': 'ESTIMATED'}, 'lastUpdatePostDateStruct': {'date': '2018-11-14', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2016-07-27', 'studyFirstPostDateStruct': {'date': '2013-05-21', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2016-09-15', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2014-05', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Percentage of Participants With Sustained Virologic Response (SVR) 12 Weeks After Discontinuation of Therapy (SVR12)', 'timeFrame': 'Posttreatment Week 12', 'description': 'SVR12 was defined as HCV RNA \\< the lower limit of quantitation (LLOQ; ie, 15 IU/mL) at 12 weeks after stopping study treatment.'}, {'measure': 'Percentage of Participants Who Permanently Discontinued Any Study Drug Due to an Adverse Event', 'timeFrame': 'Up to 12 weeks'}], 'secondaryOutcomes': [{'measure': 'Percentage of Participants With SVR at 4 and 24 Weeks After Discontinuation of Therapy (SVR4 and SVR24)', 'timeFrame': 'Posttreatment Weeks 4 and 24', 'description': 'SVR4 and SVR 24 were defined as HCV RNA \\< LLOQ at 4 and 24 weeks after stopping study treatment, respectively.'}, {'measure': 'Percentage of Participants With Virologic Failure', 'timeFrame': 'Up to Posttreatment Week 24', 'description': 'Virologic failure was defined as:\n\n* On-treatment virologic failure:\n\n * Breakthrough (confirmed HCV RNA ≥ LLOQ after having previously had HCV RNA \\< LLOQ while on treatment), or\n * Rebound (confirmed \\> 1 log10 IU/mL increase in HCV RNA from nadir while on treatment), or\n * Non-response (HCV RNA persistently ≥ LLOQ through 8 weeks of treatment)\n* Virologic relapse:\n\n * Confirmed HCV RNA ≥ LLOQ during the posttreatment period having achieved HCV RNA \\< LLOQ at last on-treatment visit.'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Hepatitis', 'HCV Genotype 1', 'HCV Genotype 2', 'HCV Genotype 3', 'HCV Genotype 4', 'HCV Genotype 5', 'HCV Genotype 6', 'treatment naive'], 'conditions': ['Hepatitis C']}, 'referencesModule': {'references': [{'type': 'RESULT', 'citation': 'Everson GT, Tran TT, Towner WJ , Davis MN, Wyles D, Nahass R, McNally J, Brainard DM, Han L, Doehle B, Mogalian E, Symonds WT, McHutchison JG, Morgan T, Chung RT. Safety and Efficacy of Treatment with the Interferon-Free, Ribavirin-Free Combination of Sofosbuvir + GS-5816 for 12 Weeks in Treatment Naive Patients with Genotype 1-6 HCV Infection. Journal of Hepatology, Volume 60, Issue 1, Supplement, Page S46. April 2014 (EASL 2014).'}, {'type': 'RESULT', 'citation': 'Tran TT, Morgan TR, Thuluvath PJ, Etzkorn K, Hinestrosa F, Tong M, McNally J, Brainard DM, Han L, Doehle B, Mogalian E, McHutchison JG, Chung RT, Everson GT. Safety and Efficacy of Treatment with Sofosbuvir+ GS-5816±Ribavirin for 8 or 12 Weeks in Treatment Naïve Patients with Genotype 1-6 HCV Infection. Hepatology (2014), 60: 4 (suppl) 237A.'}, {'type': 'RESULT', 'citation': 'Doehle B, Gontcharova V, Chodavarapu1 RK, McNally J, Chung RT, Everson GT, McHutchison JG, Miller MD, Mo H. Resistance Analysis of Treatment-Naive HCV Genotype 1-6 Infected Patients Treated with Sofosbuvir in Combination with GS-5816 for 12 Weeks. Hepatology (2014), 60: 4 (suppl) 1138A.'}, {'pmid': '26551051', 'type': 'RESULT', 'citation': 'Everson GT, Towner WJ, Davis MN, Wyles DL, Nahass RG, Thuluvath PJ, Etzkorn K, Hinestrosa F, Tong M, Rabinovitz M, McNally J, Brainard DM, Han L, Doehle B, McHutchison JG, Morgan T, Chung RT, Tran TT. Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial. Ann Intern Med. 2015 Dec 1;163(11):818-26. doi: 10.7326/M15-1000. Epub 2015 Nov 10.'}]}, 'descriptionModule': {'briefSummary': 'The primary objectives of this study are to evaluate the antiviral efficacy, safety, and tolerability of sofosbuvir (SOF) + velpatasvir (VEL; GS-5816) with or without ribavirin (RBV) in treatment-naive adults with chronic genotype (GT) 1, 2, 3, 4, 5, or 6 hepatitis C virus (HCV) infection.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Chronic HCV infection\n* Body mass index (BMI) ≥ 18 kg/m\\^2\n* HCV RNA ≥ 10000 IU/mL at screening\n* Use of highly effective contraception methods if female of childbearing potential or sexually active male\n* Must not have cirrhosis\n\nExclusion Criteria:\n\n* Current or prior history of clinically significant illness other than HCV\n* Screening ECG with clinically significant abnormalities\n* Prior exposure to HCV specific direct acting antiviral agent\n* Prior treatment of HCV with interferon or ribavirin\n* Pregnant or nursing female or male with pregnant female partner\n* Chronic liver disease of non-HCV etiology\n* Hepatitis B\n* Active drug abuse\n* Use of any prohibited concomitant medications'}, 'identificationModule': {'nctId': 'NCT01858766', 'briefTitle': 'Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection', 'organization': {'class': 'INDUSTRY', 'fullName': 'Gilead Sciences'}, 'officialTitle': 'A Phase 2, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir + GS-5816 for 12 Weeks in Treatment-Naive Subjects With Chronic HCV Infection', 'orgStudyIdInfo': {'id': 'GS-US-342-0102'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 25 mg 12 Weeks (GT1)', 'description': 'Participants with genotype 1 HCV infection will receive SOF+VEL 25 mg for 12 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 100 mg 12 Weeks (GT1)', 'description': 'Participants with genotype 1 HCV infection will receive SOF+VEL 100 mg for 12 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 25 mg 12 Weeks (GT2/4/5/6)', 'description': 'Participants with genotype 2, 4, 5, or 6 HCV infection will receive SOF+VEL 25 mg for 12 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 100 mg 12 Weeks (GT2/4/5/6)', 'description': 'Participants with genotype 2, 4, 5, or 6 HCV infection will receive SOF+VEL 100 mg for 12 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 25 mg 12 Weeks (GT3)', 'description': 'Participants with genotype 3 HCV infection will receive SOF+VEL 25 mg for 12 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 100 mg 12 Weeks (GT3)', 'description': 'Participants with genotype 3 HCV infection will receive SOF+VEL 100 mg for 12 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 25 mg 8 Weeks (GT1)', 'description': 'Participants with genotype 1 HCV infection will receive SOF+VEL 25 mg for 8 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 25 mg + RBV 8 Weeks (GT1)', 'description': 'Participants with genotype 1 HCV infection will receive SOF+VEL 25 mg plus RBV for 8 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL', 'Drug: RBV']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 100 mg 8 Weeks (GT1)', 'description': 'Participants with genotype 1 HCV infection will receive SOF+VEL 100 mg for 8 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 100 mg + RBV 8 Weeks (GT1)', 'description': 'Participants with genotype 1 HCV infection will receive SOF+VEL 100 mg plus RBV for 8 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL', 'Drug: RBV']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 25 mg 8 Weeks (GT2)', 'description': 'Participants with genotype 2 HCV infection will receive SOF+VEL 25 mg for 8 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 25 mg + RBV 8 Weeks (GT2)', 'description': 'Participants with genotype 2 HCV infection will receive SOF+VEL 25 mg plus RBV for 8 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL', 'Drug: RBV']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 100 mg 8 Weeks (GT2)', 'description': 'Participants with genotype 2 HCV infection will receive SOF+VEL 100 mg for 8 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL']}, {'type': 'EXPERIMENTAL', 'label': 'SOF+VEL 100 mg + RBV 8 Weeks (GT2)', 'description': 'Participants with genotype 2 HCV infection will receive SOF+VEL 100 mg plus RBV for 8 weeks.', 'interventionNames': ['Drug: SOF', 'Drug: VEL', 'Drug: RBV']}], 'interventions': [{'name': 'SOF', 'type': 'DRUG', 'otherNames': ['GS-7977', 'PSI-7977', 'Sovaldi®'], 'description': '400 mg tablet administered orally once daily', 'armGroupLabels': ['SOF+VEL 100 mg + RBV 8 Weeks (GT1)', 'SOF+VEL 100 mg + RBV 8 Weeks (GT2)', 'SOF+VEL 100 mg 12 Weeks (GT1)', 'SOF+VEL 100 mg 12 Weeks (GT2/4/5/6)', 'SOF+VEL 100 mg 12 Weeks (GT3)', 'SOF+VEL 100 mg 8 Weeks (GT1)', 'SOF+VEL 100 mg 8 Weeks (GT2)', 'SOF+VEL 25 mg + RBV 8 Weeks (GT1)', 'SOF+VEL 25 mg + RBV 8 Weeks (GT2)', 'SOF+VEL 25 mg 12 Weeks (GT1)', 'SOF+VEL 25 mg 12 Weeks (GT2/4/5/6)', 'SOF+VEL 25 mg 12 Weeks (GT3)', 'SOF+VEL 25 mg 8 Weeks (GT1)', 'SOF+VEL 25 mg 8 Weeks (GT2)']}, {'name': 'VEL', 'type': 'DRUG', 'otherNames': ['GS-5816'], 'description': 'Tablet administered orally once daily', 'armGroupLabels': ['SOF+VEL 100 mg + RBV 8 Weeks (GT1)', 'SOF+VEL 100 mg + RBV 8 Weeks (GT2)', 'SOF+VEL 100 mg 12 Weeks (GT1)', 'SOF+VEL 100 mg 12 Weeks (GT2/4/5/6)', 'SOF+VEL 100 mg 12 Weeks (GT3)', 'SOF+VEL 100 mg 8 Weeks (GT1)', 'SOF+VEL 100 mg 8 Weeks (GT2)', 'SOF+VEL 25 mg + RBV 8 Weeks (GT1)', 'SOF+VEL 25 mg + RBV 8 Weeks (GT2)', 'SOF+VEL 25 mg 12 Weeks (GT1)', 'SOF+VEL 25 mg 12 Weeks (GT2/4/5/6)', 'SOF+VEL 25 mg 12 Weeks (GT3)', 'SOF+VEL 25 mg 8 Weeks (GT1)', 'SOF+VEL 25 mg 8 Weeks (GT2)']}, {'name': 'RBV', 'type': 'DRUG', 'otherNames': ['Ribasphere®'], 'description': '200 mg tablets administered orally in a divided daily dose according to package insert weight-based dosing recommendations (\\< 75 kg = 1000 mg and ≥ 75 kg = 1200 mg)', 'armGroupLabels': ['SOF+VEL 100 mg + RBV 8 Weeks (GT1)', 'SOF+VEL 100 mg + RBV 8 Weeks (GT2)', 'SOF+VEL 25 mg + RBV 8 Weeks (GT1)', 'SOF+VEL 25 mg + RBV 8 Weeks (GT2)']}]}, 'contactsLocationsModule': {'locations': [{'zip': '92037', 'city': 'La Jolla', 'state': 'California', 'country': 'United States', 'facility': 'UCSD', 'geoPoint': {'lat': 32.84727, 'lon': -117.2742}}, {'zip': '92093', 'city': 'La Jolla', 'state': 'California', 'country': 'United States', 'facility': 'University of California San Diego Medical Center', 'geoPoint': {'lat': 32.84727, 'lon': -117.2742}}, {'zip': '90822', 'city': 'Long Beach', 'state': 'California', 'country': 'United States', 'facility': 'VA Long Beach Healthcare System', 'geoPoint': {'lat': 33.76696, 'lon': -118.18923}}, {'zip': '90027', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Los Angeles Medical Center', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90036', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Ruane Peter J MD Incorporated', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90048', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Cedars Sinai Medical Center', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90057', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'National Research Institute', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '91105', 'city': 'Pasadena', 'state': 'California', 'country': 'United States', 'facility': 'Huntington Medical Research Institutes Liver Center', 'geoPoint': {'lat': 34.14778, 'lon': -118.14452}}, {'zip': '92120', 'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': 'Kaiser Permanente Medical Grp', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'zip': '92123', 'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': 'Medical Associates Research Group, Inc.', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'zip': '94080', 'city': 'San Francisco', 'state': 'California', 'country': 'United States', 'facility': 'Kaiser Permante', 'geoPoint': {'lat': 37.77493, 'lon': -122.41942}}, {'zip': '80220', 'city': 'Denver', 'state': 'Colorado', 'country': 'United States', 'facility': 'University of Colorado', 'geoPoint': {'lat': 39.73915, 'lon': -104.9847}}, {'zip': '32610', 'city': 'Gainesville', 'state': 'Florida', 'country': 'United States', 'facility': 'University of Florida Center for Clinical Trials Research', 'geoPoint': {'lat': 29.65163, 'lon': -82.32483}}, {'zip': '32216', 'city': 'Jacksonville', 'state': 'Florida', 'country': 'United States', 'facility': 'Borland-Groover Clinic', 'geoPoint': {'lat': 30.33218, 'lon': -81.65565}}, {'zip': '33136', 'city': 'Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'University of Miami', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '32803', 'city': 'Orlando', 'state': 'Florida', 'country': 'United States', 'facility': 'Orlando Immunology Center', 'geoPoint': {'lat': 28.53834, 'lon': -81.37924}}, {'zip': '33606', 'city': 'Tampa', 'state': 'Florida', 'country': 'United States', 'facility': 'Tampa General Hospital', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '33414', 'city': 'Wellington', 'state': 'Florida', 'country': 'United States', 'facility': 'South Florida Center of Gastroenterology, P.A', 'geoPoint': {'lat': 26.65868, 'lon': -80.24144}}, {'zip': '30344', 'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'Center For Hepatitis C/Atlanta Medical Center', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '30060', 'city': 'Marietta', 'state': 'Georgia', 'country': 'United States', 'facility': 'Gastrointestinal Specialists of Georgia, PC', 'geoPoint': {'lat': 33.9526, 'lon': -84.54993}}, {'zip': '60611', 'city': 'Chicago', 'state': 'Illinois', 'country': 'United States', 'facility': 'Northwestern University', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'zip': '46202', 'city': 'Indianapolis', 'state': 'Indiana', 'country': 'United States', 'facility': 'Indiana University School of Medicine', 'geoPoint': {'lat': 39.76838, 'lon': -86.15804}}, {'zip': '46237', 'city': 'Indianapolis', 'state': 'Indiana', 'country': 'United States', 'facility': 'Indianapolis Gastroenterology & Hepatology, Inc.- ARC', 'geoPoint': {'lat': 39.76838, 'lon': -86.15804}}, {'zip': '21202', 'city': 'Baltimore', 'state': 'Maryland', 'country': 'United States', 'facility': 'Mercy Medical Ctr', 'geoPoint': {'lat': 39.29038, 'lon': -76.61219}}, {'zip': '21287', 'city': 'Baltimore', 'state': 'Maryland', 'country': 'United States', 'facility': 'Johns Hopkins University', 'geoPoint': {'lat': 39.29038, 'lon': -76.61219}}, {'zip': '02114', 'city': 'Boston', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Massachusetts General Hospital', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '02215', 'city': 'Boston', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Beth Israel Deaconess Medical Center', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '48202', 'city': 'Detroit', 'state': 'Michigan', 'country': 'United States', 'facility': 'Henry Ford Health System', 'geoPoint': {'lat': 42.33143, 'lon': -83.04575}}, {'zip': '08844', 'city': 'Hillsborough', 'state': 'New Jersey', 'country': 'United States', 'facility': 'ID Care', 'geoPoint': {'lat': 40.4776, 'lon': -74.62682}}, {'zip': '87505', 'city': 'Santa Fe', 'state': 'New Mexico', 'country': 'United States', 'facility': 'Southwest C.A.R.E. Center', 'geoPoint': {'lat': 35.68698, 'lon': -105.9378}}, {'zip': '11041', 'city': 'Lake Success', 'state': 'New York', 'country': 'United States', 'facility': 'North Shore/Long Island Jewish PRIME', 'geoPoint': {'lat': 40.77066, 'lon': -73.71763}}, {'zip': '10021', 'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'Weill Cornell Medical College-New York Presbyterian Hospital', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '28801', 'city': 'Asheville', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Asheville Gastroenterology Associates, P.A.', 'geoPoint': {'lat': 35.60095, 'lon': -82.55402}}, {'zip': '27710', 'city': 'Durham', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Duke University Medical Center', 'geoPoint': {'lat': 35.99403, 'lon': -78.89862}}, {'zip': '28303', 'city': 'Fayetteville', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Cumberland Research Associates, LLC', 'geoPoint': {'lat': 35.05266, 'lon': -78.87836}}, {'zip': '27103', 'city': 'Winston-Salem', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Digestive Health Specialists, PA', 'geoPoint': {'lat': 36.09986, 'lon': -80.24422}}, {'zip': '19104', 'city': 'Philadelphia', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'University of Pennsylvania Health System', 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'zip': '15213', 'city': 'Pittsburgh', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'UPMC Center For Liver Diseases', 'geoPoint': {'lat': 40.44062, 'lon': -79.99589}}, {'zip': '15240', 'city': 'Pittsburgh', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'VA Pittsburgh Healthcare System', 'geoPoint': {'lat': 40.44062, 'lon': -79.99589}}, {'zip': '02905', 'city': 'Providence', 'state': 'Rhode Island', 'country': 'United States', 'facility': 'University Gastroenterology', 'geoPoint': {'lat': 41.82399, 'lon': -71.41283}}, {'zip': '38138', 'city': 'Germantown', 'state': 'Tennessee', 'country': 'United States', 'facility': 'Gastro One', 'geoPoint': {'lat': 35.08676, 'lon': -89.81009}}, {'zip': '37211', 'city': 'Nashville', 'state': 'Tennessee', 'country': 'United States', 'facility': 'Nashville Gastrointestinal Specialists Inc.', 'geoPoint': {'lat': 36.16589, 'lon': -86.78444}}, {'zip': '76012', 'city': 'Arlington', 'state': 'Texas', 'country': 'United States', 'facility': 'Texas Clinical Research Institute, LLC', 'geoPoint': {'lat': 32.73569, 'lon': -97.10807}}, {'zip': '75203', 'city': 'Dallas', 'state': 'Texas', 'country': 'United States', 'facility': 'Methodist Transplant Physicians', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'zip': '78215', 'city': 'San Antonio', 'state': 'Texas', 'country': 'United States', 'facility': 'Alamo Medical Research, LTD d/b/a American Research Corporation', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '22031', 'city': 'Fairfax', 'state': 'Virginia', 'country': 'United States', 'facility': 'Metropolitan Research', 'geoPoint': {'lat': 38.84622, 'lon': -77.30637}}, {'zip': '22042', 'city': 'Falls Church', 'state': 'Virginia', 'country': 'United States', 'facility': 'INOVA Institute of Research & Education', 'geoPoint': {'lat': 38.88233, 'lon': -77.17109}}, {'zip': '23602', 'city': 'Newport News', 'state': 'Virginia', 'country': 'United States', 'facility': 'The Liver Institute of Virginia', 'geoPoint': {'lat': 36.98038, 'lon': -76.42975}}, {'zip': '23502', 'city': 'Norfolk', 'state': 'Virginia', 'country': 'United States', 'facility': 'Digestive and Liver Disease Specialists, Ltd.', 'geoPoint': {'lat': 36.84681, 'lon': -76.28522}}, {'zip': '98101', 'city': 'Seattle', 'state': 'Washington', 'country': 'United States', 'facility': 'Virginia Mason Medical Center', 'geoPoint': {'lat': 47.60621, 'lon': -122.33207}}, {'zip': '00909', 'city': 'Santurce', 'country': 'Puerto Rico', 'facility': 'Fundacion de Investigacion de Diego', 'geoPoint': {'lat': 18.19523, 'lon': -67.14018}}], 'overallOfficials': [{'name': 'John McNally, PhD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Gilead Sciences'}]}, 'ipdSharingStatementModule': {'url': 'http://www.gilead.com/research/disclosure-and-transparency', 'infoTypes': ['STUDY_PROTOCOL', 'SAP'], 'timeFrame': '18 months after study completion', 'ipdSharing': 'YES', 'description': 'Qualified external researchers may request IPD for this study after study completion. For more information, please visit our website at http://www.gilead.com/research/disclosure-and-transparency.', 'accessCriteria': 'A secured external environment with username, password, and RSA code.'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Gilead Sciences', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}